WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Botox for Treatment of TMJ Disorder With Bruxism

Phase 1

Withdrawn

Conditions: Bruxism
Temporomandibular Joint Disorders
Temporomandibular Joint Dysfunction Syndrome
Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint

Interventions: Drug: onabotulinumtoxinA

First Posted Date: 2014-07-28

Last Posted Date: 2018-01-23

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT02202070

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Pazopanib in Molecularly Selected Patients With Advanced NSCLC

Phase 2

Terminated

Conditions: Carcinoma, Non-Small Cell Lung
Non-Small Cell Lung Cancer
Nonsmall Cell Lung Cancer

Interventions: Drug: Pazopanib

First Posted Date: 2014-07-17

Last Posted Date: 2020-07-14

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 16

Registration Number: NCT02193152

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

EMA-Defined Tinnitus Subgroups

Completed

Conditions: Tinnitus

First Posted Date: 2014-07-16

Last Posted Date: 2016-03-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 40

Registration Number: NCT02191592

Locations: 🇺🇸
Washington University, St. Louis, Missouri, United States

Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas

Phase 1

Completed

Conditions: Lymphoma, T-Cell, Cutaneous
Hodgkin Disease
Lymphoma, T-Cell, Peripheral
Lymphoma, Large B-Cell, Diffuse

Interventions: Drug: Romidepsin
Drug: Gemcitabine
Drug: Oxaliplatin
Drug: Dexamethasone
Drug: Pegfilgrastim

First Posted Date: 2014-07-03

Last Posted Date: 2020-11-17

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 24

Registration Number: NCT02181218

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Buprenorphine Used With Treatment Resistant Depression in Older Adults

Phase 1

Completed

Conditions: Depression
Major Depressive Disorder

Interventions: Drug: venlafaxine XR
Drug: Placebo
Drug: buprenorphine

First Posted Date: 2014-07-03

Last Posted Date: 2019-06-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 18

Registration Number: NCT02181231

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts

Phase 3

Active, not recruiting

Conditions: Bronchiolitis Obliterans Syndrome (BOS)

Interventions: Combination Product: Extracorporeal Photopheresis (ECP)
Other: No intervention in the SOC / Retrospective Chart review.

First Posted Date: 2014-07-03

Last Posted Date: 2024-07-16

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 280

Registration Number: NCT02181257

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
Ohio State University, Columbus, Ohio, United States
🇺🇸
Temple University, Philadelphia, Pennsylvania, United States

and more 19 locations

Peer-Led Healthy Lifestyle Program in Supportive Housing

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Peer-Led Group Lifestyle Balance
Behavioral: Usual Care Services

First Posted Date: 2014-06-26

Last Posted Date: 2021-08-31

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 314

Registration Number: NCT02175641

Locations: 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung Cancer

Phase 1

Completed

Conditions: Carcinoma, Non-Small-Cell Lung

Interventions: Radiation: Proton beam radiation therapy (PBT)
Drug: Paclitaxel
Drug: Carboplatin

First Posted Date: 2014-06-24

Last Posted Date: 2017-12-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 23

Registration Number: NCT02172846

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Intubated ICU Patients

Terminated

Conditions: Patients Requiring Endotracheal Intubation

First Posted Date: 2014-06-23

Last Posted Date: 2018-11-15

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 8

Registration Number: NCT02171091

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy

Phase 2

Completed

Conditions: Duchenne Muscular Dystrophy

Interventions: Drug: Prednisolone

First Posted Date: 2014-06-19

Last Posted Date: 2018-12-21

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 25

Registration Number: NCT02167217

Locations: 🇺🇸
Nemours Hospital, Orlando, Florida, United States
🇺🇸
Washington University in Saint Louis, Saint Louis, Missouri, United States
🇺🇸
University of California Davis, Sacramento, California, United States

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy